BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 68 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,484,231 | -23.4% | 103,000 | -12.8% | 1.12% | -14.9% |
| Q2 2023 | $1,938,414 | -13.6% | 118,052 | -12.0% | 1.32% | -14.9% |
| Q1 2023 | $2,242,298 | -0.8% | 134,189 | -8.4% | 1.55% | +2.9% |
| Q4 2022 | $2,259,708 | -9.4% | 146,449 | -12.4% | 1.50% | -2.5% |
| Q3 2022 | $2,495,000 | -8.3% | 167,101 | +0.8% | 1.54% | -7.4% |
| Q2 2022 | $2,722,000 | -22.4% | 165,694 | -5.3% | 1.67% | -11.7% |
| Q1 2022 | $3,509,000 | -13.3% | 174,942 | +9.6% | 1.89% | -12.6% |
| Q4 2021 | $4,048,000 | -5.8% | 159,631 | +0.2% | 2.16% | +8.9% |
| Q3 2021 | $4,299,000 | -12.7% | 159,350 | -6.5% | 1.98% | -19.7% |
| Q2 2021 | $4,927,000 | +10.7% | 170,350 | +0.6% | 2.47% | -3.1% |
| Q1 2021 | $4,451,000 | +8.0% | 169,250 | +17.6% | 2.55% | -11.1% |
| Q4 2020 | $4,122,000 | +25.8% | 143,875 | +7.4% | 2.86% | +16.1% |
| Q3 2020 | $3,276,000 | +22.7% | 133,975 | +4.9% | 2.47% | +1.2% |
| Q2 2020 | $2,671,000 | +147.1% | 127,725 | +111.6% | 2.44% | +103.8% |
| Q1 2020 | $1,081,000 | – | 60,375 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |